One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogenIvan Campeotto, Sarel J. Fleishman, Adi Goldenzweig et al.|Proceedings of the National Academy of Sciences|2017Cited by 108
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line systemKathryn A. Hjerrild, Simon J. Draper, Katherine E. Wright et al.|Scientific Reports|2016Cited by 76
Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal ‘C-tag’Jing Jin, Simon J. Draper, Kathryn A. Hjerrild et al.|International Journal for Parasitology|2017Cited by 67
Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate AntigensJoseph J. Illingworth, Simon J. Draper, Daniel G. W. Alanine et al.|Frontiers in Immunology|2019Cited by 50
Design of a basigin‐mimicking inhibitor targeting the malaria invasion protein RH5Shira Warszawski, Sarel J. Fleishman, Elya Dekel et al.|Proteins Structure Function and Bioinformatics|2019Cited by 8